Breaking News

Gilead Sciences Inc (GILD)

Symbol	Exchange	Currency
GILD	Buenos Aires	ARS	Delayed
GILD	NASDAQ	USD	Real-time
GILD	Mexico	MXN	Delayed
GGILD	Milan	EUR	Real-time
GILD	TradeGate	EUR	Delayed
GILD	Frankfurt	EUR	Delayed
GILD	Xetra	EUR	Delayed
GILD	Santiago	USD	Delayed
GILD	Vienna	EUR	Delayed

Add to/Remove from a Portfolio Add to Watchlist

8,470.000 +284.000 +3.47%

31/03 - Closed. Currency in ARS ( Disclaimer )

Volume: 257
Bid/Ask: 8,398.000 / 8,470.000
Day's Range: 8,200.000 - 8,415.500

Type: Equity

Market: Argentina

ISIN: ARBCOM4601C4

News

GILD News

This page features the latest Gilead Sciences Inc share news. Assess the latest information about the Gilead Sciences Inc stock.

Gilead Sciences and Pionyr Immunotherapeutics Change Exclusive Option Agreement By Investing.com - Mar 23, 2023

Pionyr Immunotherapeutics, Inc., a company developing first-in-class Myeloid TuningTM antibody therapeutics that enhance the body’s anti-tumor immunity by altering, or “tuning,” immune cells within...

Gilead Sciences Announces Kite's Yescarta CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in OS for Initial Treatment of R/R Large B-cell Lymphoma By Investing.com - Mar 21, 2023

-- Landmark ZUMA-7 Study OS Data Reach Maturity Per Protocol, 5 Years After 1st Patient Randomized -- Kite, a Gilead Company (Nasdaq: NASDAQ:GILD), today announced the primary overall survival (OS)...

Peering Into Gilead Sciences's Recent Short Interest By Benzinga - Mar 06, 2023

Benzinga - Gilead Sciences's (NASDAQ:GILD) short percent of float has risen 3.28% since its last report. The company recently reported that it has 15.76 million shares sold short, which is 1.26% of...

Gilead Sciences Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the By Investing.com - Feb 22, 2023

Gilead Sciences, Inc. (Nasdaq: NASDAQ:GILD) today announced data evaluating lenacapavir in combination with broadly neutralizing antibodies (bNAbs) teropavimab and zinlirvimab as a potential...

Gilead Sciences' Kite Completes Acquisition of Tmunity By Investing.com - Feb 22, 2023

Gilead raised at Mizuho following updated estimates By Investing.com - Feb 14, 2023

By Michael Elkins Mizuho reiterated a Buy rating on Gilead Sciences (NASDAQ:GILD) and raised their price target on the stock to $101.00 (from $88.00) after updating peak sales estimates for GILD's HIV...

Gilead Sciences PT Raised to $101 at Mizuho Securities

Gilead Sciences PT receives Investment Bank Analyst Rating Update By Investing.com - Feb 14, 2023

Gilead Sciences PT Raised to $95 at Cowen

Gilead Sciences PT receives Investment Bank Analyst Rating Update By Investing.com - Feb 10, 2023

Gilead Sciences PT receives Investment Bank Analyst Rating Update By Investing.com - Feb 07, 2023

Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting By Benzinga - Feb 03, 2023

Benzinga - The FDA has approved Gilead Sciences Inc's (NASDAQ: GILD) Trodelvy (sacituzumab govitecan-hziy) for adult patients with advanced or metastatic breast cancer. The approval covers...

1 2 3 4 5 6 7

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	7,631.74	+11.31	+0.15%
DAX	15,628.84	+106.44	+0.69%
Euro Stoxx 50	4,315.05	+29.63	+0.69%
S&P 500	4,109.31	+58.48	+1.44%
Nikkei 225	28,041.48	+258.55	+0.93%
Dow Jones	33,274.15	+415.12	+1.26%
FTSE 100 Futures	7,645.5	+21.5	+0.28%

Brent Oil	79.94	+1.34	+1.70%
Crude Oil WTI	75.70	+1.33	+1.79%
Gold	1,986.70	-11.00	-0.55%
Silver	24.227	+0.238	+0.99%
Copper	4.0825	-0.0090	-0.22%
London Cocoa	2,160.00	+30.00	+1.41%
London Wheat	204.00	-5.75	-2.74%

U.K. 10Y	3.4930	+0.0040	+0.11%
U.K. 5Y	3.3475	-0.0025	-0.07%
U.K. 2Y	3.4365	-0.0025	-0.07%
Germany 10Y	2.2780	-0.0320	-1.39%
U.S. 10Y	3.473	-0.017	-0.48%
U.S. 5Y	3.5836	-0.0274	-0.76%
U.S. 2Y	4.0376	-0.0244	-0.60%

Lloyds Banking	47.67	-0.10	-0.20%
Vodafone Group PLC	89.30	-0.24	-0.27%
Barclays	145.80	+0.98	+0.68%
BT Group	145.80	+1.70	+1.18%
HSBC	549.70	-5.60	-1.01%
BHP Group Ltd	2,559.50	+33.00	+1.31%
Exxon Mobil	109.66	+0.17	+0.16%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILD	8,470.000	+284.000	+3.47%

Market Movers

Name	Last	Chg. %	Vol.
BP	510.80	-0.47%	45.71M
HSBC	549.70	-1.01%	29.90M
Emis Group	1,500.00	-17.22%	12.24M
Shell	2,308.5	-0.41%	9.68M
Unilever	4,190.0	-0.06%	4.63M
Reckitt Benckiser	6,158.0	-0.10%	2.20M
AstraZeneca	11,232.0	+0.59%	1.52M

Name	Last	Chg. %	Vol.
X5 Retail Group	11.00	+1000.00%	27.59K
ECSC	50.00	+150.00%	274.18K
Fix Price Group	2.23	+136.97%	178.00K
Marsh McLennan	165.97	+104.90%	1.75K
Jersey Oil and Gas	235.00	+55.23%	1.23M
Frontline	170.44	+50.44%	2.25K
Ukrproduct	3.250	+38.46%	0.10K

Name	Last	Chg. %	Vol.
Tilray	2.58	-85.75%	0
BioGaia B	91.85	-82.18%	1.36K
H Lundbeck B	31.81	-81.69%	166.73K
Atlas Copco B	119.22	-68.45%	54.78K
Tomra Systems	176.00	-49.39%	9.53K
Shearwater Group	50.00	-40.24%	637.22K
Biodexa Pharmaceuticals	7.50	-38.02%	151.25K

Webinars

The Road Less Travelled in Trading Thursday, April 20, 2023 | 18:00 BST